Veradigm Inc (MDRX)

Currency in USD
4.70
-0.10(-2.08%)
Closed·
Earnings results expected in 7 days
MDRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.204.85
52 wk Range
3.006.00
Key Statistics
Prev. Close
4.8
Open
4.2
Day's Range
4.2-4.85
52 wk Range
3-6
Volume
17.42K
Average Volume (3m)
158.06K
1-Year Change
9.3491%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MDRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.83
Upside
+24.11%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Veradigm Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 5.83
(+24.11% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Veradigm Inc Earnings Call Summary for Q4/2024

  • Q4 2024 EPS of $0.3079, slightly below $0.31 forecast; revenue met expectations at $168.7M
  • 2024 GAAP revenue $583M-$588M, with $42M shortfall; net cash position $87M
  • 2025 revenue expected flat vs 2024; focus on cost optimization and AI-enabled solutions
  • Financial reporting remediation targeted for 2026; pursuing additional debt financing
  • Stock up 1.98% in premarket to $5.15; analyst targets suggest potential upside
Last Updated: 03/19/2025, 09:14 PM
Read Full Transcript

Earnings

Latest Release
Feb 27, 2026
EPS / Forecast
0.08 / 0.07
Revenue / Forecast
149.05M / 147.6M
EPS Revisions
Last 90 days

MDRX Income Statement

Compare MDRX to Peers and Sector

Metrics to compare
MDRX
Peers
Sector
Relationship
P/E Ratio
0.0x−1.1x−0.5x
PEG Ratio
0.00−0.230.00
Price/Book
0.0x0.4x2.6x
Price / LTM Sales
0.0x2.6x3.2x
Upside (Analyst Target)
0.0%−1.1%48.8%
Fair Value Upside
Unlock−18.7%6.9%Unlock

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.80M1.06%8.62M
Other Institutional Investors
122.83M72.25%589.59M
Public Companies & Retail Investors
45.39M26.70%217.87M
Total
170.02M100.00%816.07M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Stonehill Capital Management LLC12.38%21,047,737101,029
Stonehill Institutional Partners, L.P.6.73%11,435,15154,889

People Also Watch

214.34
ITT
+0.96%
94.57
CCEP
+0.87%
527.58
CIEN
+10.98%
17.58
BAX
+4.02%

FAQ

What Is the Veradigm (MDRX) Stock Price Today?

The Veradigm stock price today is 4.70 USD.

What Stock Exchange Does Veradigm Trade On?

Veradigm is listed and trades on the OTC Markets.

What Is the Stock Symbol for Veradigm?

The stock symbol for Veradigm is "MDRX."

What Is the Veradigm Market Cap?

As of today, Veradigm market cap is 816.07M USD.

What Is Veradigm's Earnings Per Share (TTM)?

The Veradigm EPS (TTM) is -0.18.

When Is the Next Veradigm Earnings Date?

Veradigm will release its next earnings report on May 08, 2026.

From a Technical Analysis Perspective, Is MDRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Veradigm Stock Split?

Veradigm has split 0 times.

How Many Employees Does Veradigm Have?

Veradigm has 2450 employees.

What is the current trading status of Veradigm (MDRX)?

As of May 01, 2026, Veradigm (MDRX) is trading at a price of 4.70 USD, with a previous close of 4.80 USD. The stock has fluctuated within a day range of 4.20 USD to 4.85 USD, while its 52-week range spans from 3.00 USD to 6.00 USD.

What Is Veradigm (MDRX) Price Target According to Analysts?

The average 12-month price target for Veradigm is 5.83 USD, with a high estimate of 8 USD and a low estimate of 4.5 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +24.11% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.